These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 16257309

  • 1. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
    Robertson SM, Curtis MA, Schlech BA, Rusinko A, Owen GR, Dembinska O, Liao J, Dahlin DC.
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S32-45. PubMed ID: 16257309
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).
    Schlech BA, Alfonso E.
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S7-15. PubMed ID: 16257313
    [Abstract] [Full Text] [Related]

  • 6. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP, Caudle D, Aronowicz JD, Shine WE.
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ, Lane SS, Kim T, Raizman M, Dunn S.
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [Abstract] [Full Text] [Related]

  • 9. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
    Hariprasad SM, Shah GK, Chi J, Prince RA.
    J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
    [Abstract] [Full Text] [Related]

  • 10. The effect of cataract surgery on ocular levels of topical moxifloxacin.
    Mather R, Stewart JM, Prabriputaloong T, Wong J, McLeod SD.
    Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
    Fukuda M, Yamada M, Kinoshita S, Inatomi T, Ohashi Y, Uno T, Shimazaki J, Satake Y, Maeda N, Hori Y, Nishida K, Kubota A, Nakazawa T, Shimomura Y.
    Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
    [Abstract] [Full Text] [Related]

  • 13. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.
    Ong-Tone L.
    J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
    Lai WW, Chu KO, Chan KP, Choy KW, Wang CC, Tsang CW, Pang CP.
    Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
    Vasavada AR, Gajjar D, Raj SM, Vasavada V, Vasavada V.
    J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.